UBC Medical Indonesia Tbk. (LABS)

Update terakhir: 12 Desember 2025 17.17 WIB

Rp 140

0,00(0,00%)

POSTPOST
Ringkasan Pasar
  • Harga Pasar: Rp 140
  • Volume Perdagangan: Rp 589.700
  • Kapitalisasi Pasar: Rp 553.000.042.496
  • Mata Uang: IDR
  • Pasar: id_market
Rasio dan Dividen
  • Dividend Yield: -%
  • Dividend Rate: Rp -
  • Price to Book: 3,67
  • Forward P/E: -
  • Trailing P/E: -
  • EPS Tahun Ini: Rp -
  • EPS Perkiraan: Rp -
Teknikal & Statistik Perdagangan
  • Bid: Rp 139,00
  • Ask: Rp 140,00
  • Bid Size: -
  • Ask Size: -
  • Volume Rata-rata 10 Hari: 984.250
  • Volume Rata-rata 3 Bulan: 1.950.001
  • Book Value: Rp 38,16
  • Fifty Day Average: Rp 142,48
  • Two Hundred Day Average: Rp 132,84
  • 52 Week Range: 107.0 - 165.0
  • 52 Week High: Rp 165,00
  • 52 Week Low: Rp 107,00
  • Regular Market Open: Rp 142,00
  • Regular Market Previous Close: Rp 140,00
  • Regular Market Day High: Rp 142,00
  • Regular Market Day Low: Rp 138,00
  • Earnings Call Start: -
  • Earnings Call End: -
  • Earnings Timestamp: -
Informasi Perusahaan & Sektor

Sektor

Healthcare

Industri

Medical Devices

Alamat Perusahaan

Etana Building

3rd Floor, Pulogadung Industrial Area Jl. Rawagelam V, Blok L, No Kav 11-13 Kel. Jatinegara, District. Cakung

Jakarta Timur

Ringkasan Bisnis

PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. It operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. The company offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products. PT UBC Medical Indonesia Tbk was founded in 2014 and is based in Jakarta Timur, Jakarta. PT UBC Medical Indonesia Tbk operates as a subsidiary of PT Optel Investama Mulia.

Ebook ProfitWise - Metode FCDS-T

Ebook ProfitWise - Metode FCDS-T mencari Saham MultiBagger(Terjual ke 2000+ Investor)

IDR 199,000IDR 350,000Hanya 9 tersisa!

Metode FCDS-T: Strategi investasi dengan CAGR >35% yang membantu modal Rp100 juta berkembang menjadi Rp1,1 miliar dalam 8 tahun.

Cocok untuk investor yang ingin:

  • Memiliki sinyal jual/beli jelas
  • Aturan investasi objektif (tanpa emosi)
  • Menghemat waktu (hanya 4x analisis/tahun)
  • Mencapai tujuan finansial

Bonus: Template spreadsheet + Konsultasi gratis!

Dapatkan Sekarang